CoChat
Sign Up
Cited by 337

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The medical effects of mold exposure

Bush, Robert K., Portnoy, Jay M., Saxon, Andrew, Terr, Abba I., Wood, Robert A.·2006·Journal of Allergy and Clinical Immunology
DOI 10.1016/j.jaci.2005.12.001
Open this paper in CoChat — free account

Abstract

Exposure to molds can cause human disease through several well-defined mechanisms. In addition, many new mold-related illnesses have been hypothesized in recent years that remain largely or completely unproved. Concerns about mold exposure and its effects are so common that all health care providers, particularly allergists and immunologists, are frequently faced with issues regarding these real and asserted mold-related illnesses. The purpose of this position paper is to provide a state-of-the-art review of the role that molds are known to play in human disease, including asthma, allergic rhinitis, allergic bronchopulmonary aspergillosis, sinusitis, and hypersensitivity pneumonitis. In addition, other purported mold-related illnesses and the data that currently exist to support them are carefully reviewed, as are the currently available approaches for the evaluation of both patients and the environment.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2005.12.001

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 2 references

Research works printed but not linked: 32

  1. Bush, 2004, Alternaria-induced asthma, J Allergy Clin Immunol, 113, 227, 10.1016/j.jaci.2003.11.023 · DOI
  2. Delfino, 1996, Daily asthma severity in relation to personal ozone exposure and outdoor fungal spores, Am J Respir Crit Care Med, 154, 633, 10.1164/ajrccm.154.3.8810598 · DOI
  3. Peat, 1998, Effects of damp and mould in the home on respiratory health: a review of the literature, Allergy, 53, 120, 10.1111/j.1398-9995.1998.tb03859.x · DOI
  4. Gent, 2002, Levels of household mold associated with respiratory symptoms in the first year of life in a cohort at risk for asthma, Environ Health Perspect, 110, A781, 10.1289/ehp.021100781 · DOI
  5. Belanger, 2003, Symptoms of wheeze and persistent cough in the first year of life: association with indoor allergens air contaminants, and maternal history of asthma, Am J Epidemiol, 158, 195, 10.1093/aje/kwg148 · DOI
  6. Andersson, 2003, Natural exposure to Alternaria spores induces allergic rhinitis symptoms in sensitized children, Pediatr Allergy Immunol, 14, 100, 10.1034/j.1399-3038.2003.00031.x · DOI
  7. Helbling, 1998, Mushroom (basidiomycete) allergy: diagnosis established by skin test and nasal challenge, J Allergy Clin Immunol, 83, 853, 10.1016/S0091-6749(98)70028-4 · DOI
  8. Gergen, 1992, The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II), J Allergy Clin Immunol, 90, 579, 10.1016/0091-6749(92)90130-T · DOI
  9. Rowe, 1986, Evaluation of the cause of nasal and ocular symptoms associated with lawn mowing, J Allergy Clin Immunol, 77, 714, 10.1016/0091-6749(86)90416-1 · DOI
  10. Lander, 2001, Serum IgE specific to indoor moulds, measured by basophil histamine release, is associated with building-related symptoms in damp buildings, Inflamm Res, 50, 227, 10.1007/s000110050748 · DOI
  11. Katz, 1999, Indoor survey of moulds and prevalence of mould atopy in Israel, Clin Exp Allergy, 2, 186, 10.1046/j.1365-2222.1999.00403.x · DOI
  12. Huang, 1997, Mold allergy is a risk factor for persistent cold-like symptoms in children, Clin Pediatr (Phila), 36, 695, 10.1177/000992289703601205 · DOI
  13. Montealegre, 2004, Comparative prevalence of sensitization to common animal, plant and mould allergens in subjects with asthma, or atopic dermatitis and/or allergic rhinitis living in a tropical environment, Clin Exp Allergy, 34, 51, 10.1111/j.1365-2222.2004.01855.x · DOI
  14. Reijula, 2003, IgE-mediated allergy to fungal allergens in Finland with special reference to Alternaria alternata and Cladosporium herbarium, Ann Allergy Asthma Immunol, 91, 280, 10.1016/S1081-1206(10)63531-4 · DOI
  15. Scalabrin, 1999, Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and non-asthmatic control subjects, J Allergy Clin Immunol, 104, 1273, 10.1016/S0091-6749(99)70024-2 · DOI
  16. Greenberger, 2002, Allergic bronchopulmonary aspergillosis, J Allergy Clin Immunol, 110, 685, 10.1067/mai.2002.130179 · DOI
  17. Luong, 2004, Allergic fungal rhinosinusitis, Curr Allergy Asthma Rep, 4, 465, 10.1007/s11882-004-0013-5 · DOI
  18. Bush, 2005, Is topical antifungal therapy effective in the treatment of chronic rhinosinusitis?, J Allergy Clin Immunol, 115, 123, 10.1016/j.jaci.2004.10.025 · DOI
  19. Fung, 2004, Health effects of mycotoxins: a toxicological overview, Toxicol Clin Toxicol, 42, 217, 10.1081/CLT-120030947 · DOI
  20. Monaci, 2004, Determination of ochratoxin A in foods: state-of-the-art and analytical challenges, Anal Bioanal Chem, 378, 96, 10.1007/s00216-003-2364-5 · DOI
  21. Robbins, 2004, Risk from inhaled mycotoxins in indoor office and residential environments, Int J Toxicol, 23, 3, 10.1080/10915810490265423 · DOI
  22. Pasanen, 1998, Critical aspects on the significance of microbial volatile metabolites as indoor air pollutants, Environ Int, 24, 703, 10.1016/S0160-4120(98)00065-8 · DOI
  23. Pasanen, 1996, Volatile organic metabolites associated with some toxic fungi and their mycotoxins, Analyst, 121, 1949, 10.1039/an9962101949 · DOI
  24. Roponen, 2002, Fungal spores as such do not cause nasal inflammation in mold exposure, Inhal Toxicol, 14, 541, 10.1080/089583701753678616 · DOI
  25. Gray, 2003, Mixed mold mycotoxicosis: immunological changes in humans following exposure in water-damaged buildings, Arch Environ Health, 58, 410, 10.1080/00039896.2003.11879142 · DOI
  26. Campbell, 2004, Mold and mycotoxins: effects on the neurological and immune systems in humans, Adv Appl Microbiol, 55, 375, 10.1016/S0065-2164(04)55015-3 · DOI
  27. Salvaggio, 1994, Use and misuse of biomarker tests in “environmental conditions”, J Allergy Clin Immunol, 94, 380, 10.1053/ai.1994.v94.a56018 · DOI
  28. Hamilton, 2004, In vitro assays for the diagnosis of IgE-mediated disorders, J Allergy Clin Immunol, 114, 213, 10.1016/j.jaci.2004.06.046 · DOI
  29. Trout, 2004, Clinical use of immunoassays in assessing exposure to fungi and potential health effects related to fungal exposure, Ann Allergy Asthma Immunol, 92, 483, 10.1016/S1081-1206(10)61754-1 · DOI
  30. Taskinen, 2002, Immunoglobulin G antibodies to moulds in school-children from moisture problem schools, Allergy, 57, 9, 10.1034/j.1398-9995.2002.13154.x · DOI
  31. 2005, Surveillance for illness and injury after hurricane Katrina—New Orleans, Louisiana, September 8-25, 2005, MMWR Morb Mortal Wkly Rep, 54, 1018
  32. 2005, Science after Katrina, Nature, 437, 452, 10.1038/437452a · DOI

Cited by

Sorted by citations

See all 337

Metadata

Authors
Bush, R. K., Portnoy, J. M., Saxon, A., Terr, A. I., & Wood, R. A.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2006-02
Volume
117
Issue
2
Pages
326-333
ISSN
0091-6749
DOI
10.1016/j.jaci.2005.12.001
Cited by
337
References
2
Language
en
Update notices
erratum (2006-06-01)
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review